Abstract |
Tridentate chelating agents, as potential antitumor agents, were prepared by condensing 2-quinolylhydrazines, 2-pyridylhydrazine and 2-benzothiazolylhydrazine with pyridine-2-aldehyde, 6-methylpyridine-2-aldehyde, 2-acetylpyridine and 2-benzoylpyridine. All compounds were tested against Lymphocytic leukemia P388. The active pyridine-2-aldehyde-4-methyl-2-quinolylhydrazone [1-(4'-methyl-2'-quinolyl)-3-(2'-pyridyl)-1,2-diaza-2- propene] (I d) was also tested against other experimental tumors and proved inactive.
|
Authors | C Pellerano, L Savini, P Massarelli |
Journal | Il Farmaco; edizione scientifica
(Farmaco Sci)
Vol. 40
Issue 9
Pg. 645-54
(Sep 1985)
ISSN: 0430-0920 [Print] Italy |
Vernacular Title | Sistemi chelanti tridentati N-N-N quali potenziali agenti antitumorali. |
PMID | 4076429
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Chelating Agents
- Hydrazones
|
Topics |
- Animals
- Antineoplastic Agents
(administration & dosage, chemical synthesis)
- Cell Line
- Chelating Agents
(administration & dosage, chemical synthesis)
- Chemical Phenomena
- Chemistry
- Female
- Hydrazones
(pharmacology)
- Leukemia P388
(drug therapy)
- Male
- Mice
|